Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Brainsway Ltd

Brainsway Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)9.50
  • Today's Change-0.10 / -1.04%
  • Shares traded80.17k
  • 1 Year change+136.91%
  • Beta1.2580
Data delayed at least 15 minutes, as of Oct 04 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

  • Revenue in USD (TTM)63.57m
  • Net income in USD-8.39m
  • Incorporated2006
  • Employees134.00
  • Location
    Brainsway Ltd19 Hartum StBynet Building, Har HotzvimJERUSALEM 9777518IsraelISR
  • Phone+972 25824030
  • Fax+972 25812517
  • Websitehttps://www.brainsway.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Baird Medical Investment Holdings Ltd0.00-4.88m112.10m----12.58-----0.7412-0.74120.000.34340.00-------14.19---20.29--------------0.3413-------627.59------
KORU Medical Systems Inc30.82m-11.76m120.14m82.00--6.42--3.90-0.2574-0.25740.67420.40820.97372.946.50375,817.30-37.15-17.60-43.48-20.2962.4959.44-38.16-21.703.27--0.0195--2.2310.44-58.65--11.10--
908 Devices Inc.52.69m-37.99m121.30m230.00--0.7752--2.30-1.15-1.151.604.520.25111.544.95229,069.60-18.11-14.16-20.12-15.3552.3253.02-72.10-64.254.23--0.00--7.2117.89-8.45--22.98--
Myomo Inc21.11m-9.45m121.51m101.00--12.55--5.76-0.2614-0.26140.58330.32041.433.5010.13209,020.40-64.07-81.78-101.11-115.2767.3568.50-44.75-85.761.94--0.00--23.7051.0924.00--2.82--
EUDA Health Holdings Ltd3.71m-8.44m135.24m106.00------36.49-0.3685-0.43840.1707-0.30450.2752--3.5534,966.61-62.62------22.72---227.57-----1.49-----1.54--66.17------
Akoya Biosciences Inc93.22m-60.35m137.61m330.00--6.18--1.48-1.22-1.221.890.44980.56051.936.34282,472.70-36.29---45.98--57.57---64.74--1.98-8.000.7755--29.09--10.36------
InfuSystem Holdings Inc129.37m366.00k143.88m499.00431.032.6911.481.110.01570.01575.992.511.2210.386.44259,264.500.34654.600.4015.6949.6856.430.28294.071.641.970.38980.0014.4413.384,744.44--6.01--
Brainsway Ltd - ADR63.57m-8.39m151.55m134.00------2.38-0.5071-0.50713.86--0.49882.207.37---6.59---8.54--73.86---13.20--5.49------16.96--68.56------
Acme United Corp192.71m19.45m155.63m645.008.471.506.220.80764.974.9748.5928.131.152.074.83298,770.5011.607.0913.798.2939.4035.7210.095.501.776.600.262118.81-1.276.88486.3131.089.024.84
Stereotaxis Inc23.75m-22.08m172.70m122.00--14.91--7.27-0.265-0.2650.2850.2020.56321.145.04194,639.30-49.21-25.02-71.93-34.1259.2867.57-87.38-41.901.53--0.00---4.89-1.82-12.33--6.63--
Semler Scientific Inc61.74m15.82m174.74m92.0012.292.2310.602.832.032.037.9311.220.770616.269.15671,097.8019.7438.8322.0044.4188.6790.2225.6232.583.66--0.00--20.2825.9843.6932.64-0.3821--
Trubridge Inc336.56m-52.28m177.73m3.22k--0.9804--0.5281-3.68-3.6823.6412.120.7947196.765.88104,553.30-12.661.25-14.341.4148.7050.40-15.931.561.760.61150.498545.063.913.89-387.73--88.71--
Electromed Inc54.72m5.15m182.05m174.0037.404.2030.393.330.57910.57916.175.161.123.272.25314,459.8010.518.6412.5110.0976.2676.269.418.065.27--0.000.0013.8311.8262.6721.06-22.23--
Senseonics Holdings Inc24.04m-80.46m183.70m132.00--317.65--7.64-0.1323-0.13230.03950.07140.18152.585.99182,113.60-60.74-73.65-74.52-106.9712.04-40.41-334.69-649.862.89-10.930.5802--36.623.43-142.49---18.76--
Nevro Corp426.10m-77.44m185.30m1.22k--0.6742--0.4349-2.12-2.1211.697.370.72661.115.93350,697.90-13.21-13.64-15.59-16.6868.0668.54-18.18-20.673.53-28.950.4433--4.631.88-3,172.74--0.9012--
Orchestra Biomed Holdings Inc2.08m-55.58m188.37m56.00--4.04--90.60-1.57-1.570.05861.230.0211.3416.5737,125.00-56.06---64.66--92.02---2,673.26--4.58--0.00---21.88---37.91------
Data as of Oct 04 2024. Currency figures normalised to Brainsway Ltd's reporting currency: US Dollar USD

Institutional shareholders

19.73%Per cent of shares held by top holders
HolderShares% Held
Masters Capital Management LLCas of 31 Mar 2024900.00k5.40%
Phoenix Investments House Ltd.as of 31 Mar 2024836.90k5.02%
Essex Investment Management Co. LLCas of 31 Mar 2024324.84k1.95%
DAFNA Capital Management LLCas of 31 Mar 2024297.66k1.79%
Renaissance Technologies LLCas of 30 Jun 2024277.10k1.66%
Acadian Asset Management LLCas of 30 Jun 2024259.79k1.56%
Marshall Wace LLPas of 31 Mar 2024147.91k0.89%
Legato Capital Management LLCas of 30 Jun 2024117.21k0.70%
Walleye Capital LLCas of 31 Mar 202470.12k0.42%
Citadel Securities LLCas of 31 Mar 202456.95k0.34%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.